Nmc Health Plc (NASDAQ:NMHLY) has been given a consensus broker rating score of 3.00 (Hold) from the one brokers that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a hold rating.
Zacks has also assigned Nmc Health Plc an industry rank of 116 out of 265 based on the ratings given to its competitors.
Separately, Zacks Investment Research upgraded Nmc Health Plc from a “hold” rating to a “buy” rating and set a $41.00 target price on the stock in a report on Thursday, October 5th.
TRADEMARK VIOLATION WARNING: “Zacks: Nmc Health Plc (NMHLY) Given Consensus Recommendation of “Hold” by Analysts” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/11/12/zacks-nmc-health-plc-nmhly-given-consensus-recommendation-of-hold-by-analysts.html.
Get a free copy of the Zacks research report on Nmc Health Plc (NMHLY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nmc Health Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nmc Health Plc and related companies with MarketBeat.com's FREE daily email newsletter.